nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CYP3A4—type 2 diabetes mellitus	0.257	1	CbGaD
Tiotropium—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0398	0.101	CbGbCtD
Tiotropium—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0393	0.0999	CbGbCtD
Tiotropium—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0368	0.0934	CbGbCtD
Tiotropium—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.035	0.089	CbGbCtD
Tiotropium—CYP3A4—Glipizide—type 2 diabetes mellitus	0.032	0.0814	CbGbCtD
Tiotropium—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0302	0.0767	CbGbCtD
Tiotropium—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0289	0.0735	CbGbCtD
Tiotropium—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.028	0.0711	CbGbCtD
Tiotropium—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0253	0.0643	CbGbCtD
Tiotropium—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0192	0.0488	CbGbCtD
Tiotropium—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0184	0.0468	CbGbCtD
Tiotropium—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0184	0.0468	CbGbCtD
Tiotropium—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0174	0.0442	CbGbCtD
Tiotropium—CYP3A4—Glyburide—type 2 diabetes mellitus	0.013	0.0329	CbGbCtD
Tiotropium—CYP3A4—Losartan—type 2 diabetes mellitus	0.0119	0.0301	CbGbCtD
Tiotropium—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000249	0.001	CcSEcCtD
Tiotropium—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000248	0.001	CcSEcCtD
Tiotropium—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000248	0.001	CcSEcCtD
Tiotropium—Cough—Orlistat—type 2 diabetes mellitus	0.000248	0.001	CcSEcCtD
Tiotropium—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000247	0.000999	CcSEcCtD
Tiotropium—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000247	0.000998	CcSEcCtD
Tiotropium—Vision blurred—Metformin—type 2 diabetes mellitus	0.000247	0.000997	CcSEcCtD
Tiotropium—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000246	0.000994	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000246	0.000992	CcSEcCtD
Tiotropium—Chest pain—Valsartan—type 2 diabetes mellitus	0.000245	0.000989	CcSEcCtD
Tiotropium—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000245	0.000989	CcSEcCtD
Tiotropium—Myalgia—Valsartan—type 2 diabetes mellitus	0.000245	0.000989	CcSEcCtD
Tiotropium—Dizziness—Glipizide—type 2 diabetes mellitus	0.000245	0.000987	CcSEcCtD
Tiotropium—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000244	0.000986	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000243	0.000982	CcSEcCtD
Tiotropium—Angiopathy—Losartan—type 2 diabetes mellitus	0.000243	0.000979	CcSEcCtD
Tiotropium—Chest pain—Orlistat—type 2 diabetes mellitus	0.000242	0.000977	CcSEcCtD
Tiotropium—Myalgia—Orlistat—type 2 diabetes mellitus	0.000242	0.000977	CcSEcCtD
Tiotropium—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000241	0.000972	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00024	0.00097	CcSEcCtD
Tiotropium—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00024	0.000967	CcSEcCtD
Tiotropium—Sinusitis—Ramipril—type 2 diabetes mellitus	0.00024	0.000967	CcSEcCtD
Tiotropium—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000239	0.000964	CcSEcCtD
Tiotropium—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000237	0.000956	CcSEcCtD
Tiotropium—Vomiting—Glipizide—type 2 diabetes mellitus	0.000235	0.000949	CcSEcCtD
Tiotropium—Syncope—Metformin—type 2 diabetes mellitus	0.000235	0.000949	CcSEcCtD
Tiotropium—Oedema—Valsartan—type 2 diabetes mellitus	0.000235	0.000948	CcSEcCtD
Tiotropium—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000234	0.000946	CcSEcCtD
Tiotropium—Infection—Valsartan—type 2 diabetes mellitus	0.000233	0.000942	CcSEcCtD
Tiotropium—Rash—Glipizide—type 2 diabetes mellitus	0.000233	0.000941	CcSEcCtD
Tiotropium—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000233	0.000941	CcSEcCtD
Tiotropium—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000233	0.000941	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000233	0.00094	CcSEcCtD
Tiotropium—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000233	0.00094	CcSEcCtD
Tiotropium—Oedema—Orlistat—type 2 diabetes mellitus	0.000232	0.000937	CcSEcCtD
Tiotropium—Headache—Glipizide—type 2 diabetes mellitus	0.000232	0.000935	CcSEcCtD
Tiotropium—Palpitations—Metformin—type 2 diabetes mellitus	0.000232	0.000935	CcSEcCtD
Tiotropium—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000231	0.000933	CcSEcCtD
Tiotropium—Shock—Valsartan—type 2 diabetes mellitus	0.000231	0.000933	CcSEcCtD
Tiotropium—Infection—Orlistat—type 2 diabetes mellitus	0.000231	0.000931	CcSEcCtD
Tiotropium—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00023	0.00093	CcSEcCtD
Tiotropium—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00023	0.00093	CcSEcCtD
Tiotropium—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00023	0.000927	CcSEcCtD
Tiotropium—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000228	0.000921	CcSEcCtD
Tiotropium—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000228	0.000921	CcSEcCtD
Tiotropium—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000228	0.000919	CcSEcCtD
Tiotropium—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000228	0.000918	CcSEcCtD
Tiotropium—Hypertension—Metformin—type 2 diabetes mellitus	0.000226	0.000913	CcSEcCtD
Tiotropium—Urticaria—Glyburide—type 2 diabetes mellitus	0.000226	0.000913	CcSEcCtD
Tiotropium—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000226	0.000912	CcSEcCtD
Tiotropium—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000226	0.000912	CcSEcCtD
Tiotropium—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000225	0.00091	CcSEcCtD
Tiotropium—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000225	0.000909	CcSEcCtD
Tiotropium—Back pain—Losartan—type 2 diabetes mellitus	0.000225	0.000909	CcSEcCtD
Tiotropium—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000225	0.000908	CcSEcCtD
Tiotropium—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000225	0.000908	CcSEcCtD
Tiotropium—Myalgia—Metformin—type 2 diabetes mellitus	0.000223	0.000901	CcSEcCtD
Tiotropium—Chest pain—Metformin—type 2 diabetes mellitus	0.000223	0.000901	CcSEcCtD
Tiotropium—Headache—Pioglitazone—type 2 diabetes mellitus	0.000222	0.000896	CcSEcCtD
Tiotropium—Syncope—Irbesartan—type 2 diabetes mellitus	0.000222	0.000895	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000222	0.000894	CcSEcCtD
Tiotropium—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000221	0.000892	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000221	0.000891	CcSEcCtD
Tiotropium—Nausea—Glipizide—type 2 diabetes mellitus	0.00022	0.000887	CcSEcCtD
Tiotropium—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00022	0.000886	CcSEcCtD
Tiotropium—Vision blurred—Losartan—type 2 diabetes mellitus	0.000219	0.000885	CcSEcCtD
Tiotropium—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000219	0.000883	CcSEcCtD
Tiotropium—Constipation—Gliclazide—type 2 diabetes mellitus	0.000219	0.000882	CcSEcCtD
Tiotropium—Rash—Glimepiride—type 2 diabetes mellitus	0.000218	0.000879	CcSEcCtD
Tiotropium—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000217	0.000878	CcSEcCtD
Tiotropium—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000217	0.000877	CcSEcCtD
Tiotropium—Rash—Sitagliptin—type 2 diabetes mellitus	0.000217	0.000876	CcSEcCtD
Tiotropium—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000217	0.000875	CcSEcCtD
Tiotropium—Headache—Glimepiride—type 2 diabetes mellitus	0.000216	0.000873	CcSEcCtD
Tiotropium—Cough—Irbesartan—type 2 diabetes mellitus	0.000216	0.000871	CcSEcCtD
Tiotropium—Headache—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00087	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000214	0.000864	CcSEcCtD
Tiotropium—Oedema—Metformin—type 2 diabetes mellitus	0.000214	0.000863	CcSEcCtD
Tiotropium—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000214	0.000862	CcSEcCtD
Tiotropium—Angioedema—Losartan—type 2 diabetes mellitus	0.000213	0.000858	CcSEcCtD
Tiotropium—Infection—Metformin—type 2 diabetes mellitus	0.000213	0.000858	CcSEcCtD
Tiotropium—Insomnia—Valsartan—type 2 diabetes mellitus	0.000212	0.000857	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000211	0.000853	CcSEcCtD
Tiotropium—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000211	0.000851	CcSEcCtD
Tiotropium—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000211	0.00085	CcSEcCtD
Tiotropium—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000211	0.00085	CcSEcCtD
Tiotropium—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000211	0.00085	CcSEcCtD
Tiotropium—Shock—Metformin—type 2 diabetes mellitus	0.00021	0.000849	CcSEcCtD
Tiotropium—Insomnia—Orlistat—type 2 diabetes mellitus	0.00021	0.000847	CcSEcCtD
Tiotropium—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00021	0.000847	CcSEcCtD
Tiotropium—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00021	0.000847	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000209	0.000844	CcSEcCtD
Tiotropium—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000209	0.000844	CcSEcCtD
Tiotropium—Syncope—Losartan—type 2 diabetes mellitus	0.000209	0.000842	CcSEcCtD
Tiotropium—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000208	0.000841	CcSEcCtD
Tiotropium—Skin disorder—Metformin—type 2 diabetes mellitus	0.000208	0.000839	CcSEcCtD
Tiotropium—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000207	0.000836	CcSEcCtD
Tiotropium—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000207	0.000834	CcSEcCtD
Tiotropium—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000207	0.000834	CcSEcCtD
Tiotropium—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000206	0.000831	CcSEcCtD
Tiotropium—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000206	0.000831	CcSEcCtD
Tiotropium—Palpitations—Losartan—type 2 diabetes mellitus	0.000206	0.00083	CcSEcCtD
Tiotropium—Nausea—Glimepiride—type 2 diabetes mellitus	0.000205	0.000828	CcSEcCtD
Tiotropium—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000205	0.000827	CcSEcCtD
Tiotropium—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000205	0.000826	CcSEcCtD
Tiotropium—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000204	0.000825	CcSEcCtD
Tiotropium—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000204	0.000825	CcSEcCtD
Tiotropium—Cough—Losartan—type 2 diabetes mellitus	0.000203	0.00082	CcSEcCtD
Tiotropium—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000203	0.00082	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000203	0.000818	CcSEcCtD
Tiotropium—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000202	0.000816	CcSEcCtD
Tiotropium—Oedema—Irbesartan—type 2 diabetes mellitus	0.000202	0.000815	CcSEcCtD
Tiotropium—Pruritus—Glyburide—type 2 diabetes mellitus	0.000201	0.000813	CcSEcCtD
Tiotropium—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000201	0.000811	CcSEcCtD
Tiotropium—Constipation—Valsartan—type 2 diabetes mellitus	0.000201	0.000811	CcSEcCtD
Tiotropium—Infection—Irbesartan—type 2 diabetes mellitus	0.000201	0.000809	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.0002	0.000809	CcSEcCtD
Tiotropium—Malnutrition—Ramipril—type 2 diabetes mellitus	0.0002	0.000806	CcSEcCtD
Tiotropium—Shock—Irbesartan—type 2 diabetes mellitus	0.000199	0.000802	CcSEcCtD
Tiotropium—Chest pain—Losartan—type 2 diabetes mellitus	0.000198	0.0008	CcSEcCtD
Tiotropium—Arthralgia—Losartan—type 2 diabetes mellitus	0.000198	0.0008	CcSEcCtD
Tiotropium—Myalgia—Losartan—type 2 diabetes mellitus	0.000198	0.0008	CcSEcCtD
Tiotropium—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000198	0.000799	CcSEcCtD
Tiotropium—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000198	0.000799	CcSEcCtD
Tiotropium—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000197	0.000795	CcSEcCtD
Tiotropium—Rash—Bromocriptine—type 2 diabetes mellitus	0.000196	0.000793	CcSEcCtD
Tiotropium—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000196	0.000792	CcSEcCtD
Tiotropium—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000196	0.000791	CcSEcCtD
Tiotropium—Headache—Bromocriptine—type 2 diabetes mellitus	0.000195	0.000787	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000195	0.000787	CcSEcCtD
Tiotropium—Dry mouth—Losartan—type 2 diabetes mellitus	0.000194	0.000782	CcSEcCtD
Tiotropium—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000192	0.000775	CcSEcCtD
Tiotropium—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000192	0.000775	CcSEcCtD
Tiotropium—Oedema—Losartan—type 2 diabetes mellitus	0.00019	0.000767	CcSEcCtD
Tiotropium—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00019	0.000766	CcSEcCtD
Tiotropium—Infection—Losartan—type 2 diabetes mellitus	0.000189	0.000762	CcSEcCtD
Tiotropium—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000188	0.00076	CcSEcCtD
Tiotropium—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000188	0.00076	CcSEcCtD
Tiotropium—Shock—Losartan—type 2 diabetes mellitus	0.000187	0.000754	CcSEcCtD
Tiotropium—Urticaria—Valsartan—type 2 diabetes mellitus	0.000187	0.000753	CcSEcCtD
Tiotropium—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000186	0.000752	CcSEcCtD
Tiotropium—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000186	0.000749	CcSEcCtD
Tiotropium—Tachycardia—Losartan—type 2 diabetes mellitus	0.000185	0.000748	CcSEcCtD
Tiotropium—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000185	0.000747	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000185	0.000745	CcSEcCtD
Tiotropium—Urticaria—Orlistat—type 2 diabetes mellitus	0.000184	0.000744	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000184	0.000742	CcSEcCtD
Tiotropium—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000183	0.000741	CcSEcCtD
Tiotropium—Constipation—Metformin—type 2 diabetes mellitus	0.000183	0.000738	CcSEcCtD
Tiotropium—Angioedema—Ramipril—type 2 diabetes mellitus	0.000182	0.000736	CcSEcCtD
Tiotropium—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000181	0.000732	CcSEcCtD
Tiotropium—Vomiting—Glyburide—type 2 diabetes mellitus	0.000181	0.000731	CcSEcCtD
Tiotropium—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000181	0.00073	CcSEcCtD
Tiotropium—Rash—Glyburide—type 2 diabetes mellitus	0.00018	0.000725	CcSEcCtD
Tiotropium—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000179	0.000724	CcSEcCtD
Tiotropium—Syncope—Ramipril—type 2 diabetes mellitus	0.000179	0.000722	CcSEcCtD
Tiotropium—Headache—Glyburide—type 2 diabetes mellitus	0.000178	0.00072	CcSEcCtD
Tiotropium—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000178	0.000717	CcSEcCtD
Tiotropium—Palpitations—Ramipril—type 2 diabetes mellitus	0.000176	0.000712	CcSEcCtD
Tiotropium—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000175	0.000708	CcSEcCtD
Tiotropium—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000175	0.000706	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000174	0.000703	CcSEcCtD
Tiotropium—Cough—Ramipril—type 2 diabetes mellitus	0.000174	0.000703	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000173	0.000699	CcSEcCtD
Tiotropium—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000173	0.000698	CcSEcCtD
Tiotropium—Constipation—Irbesartan—type 2 diabetes mellitus	0.000173	0.000697	CcSEcCtD
Tiotropium—Insomnia—Losartan—type 2 diabetes mellitus	0.000172	0.000693	CcSEcCtD
Tiotropium—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000171	0.00069	CcSEcCtD
Tiotropium—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000171	0.000688	CcSEcCtD
Tiotropium—Urticaria—Metformin—type 2 diabetes mellitus	0.00017	0.000686	CcSEcCtD
Tiotropium—Chest pain—Ramipril—type 2 diabetes mellitus	0.00017	0.000686	CcSEcCtD
Tiotropium—Arthralgia—Ramipril—type 2 diabetes mellitus	0.00017	0.000686	CcSEcCtD
Tiotropium—Myalgia—Ramipril—type 2 diabetes mellitus	0.00017	0.000686	CcSEcCtD
Tiotropium—Nausea—Glyburide—type 2 diabetes mellitus	0.000169	0.000683	CcSEcCtD
Tiotropium—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000169	0.000682	CcSEcCtD
Tiotropium—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000169	0.000682	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000169	0.000681	CcSEcCtD
Tiotropium—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000167	0.000675	CcSEcCtD
Tiotropium—Pruritus—Valsartan—type 2 diabetes mellitus	0.000166	0.000671	CcSEcCtD
Tiotropium—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000166	0.000671	CcSEcCtD
Tiotropium—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000165	0.000666	CcSEcCtD
Tiotropium—Pruritus—Orlistat—type 2 diabetes mellitus	0.000164	0.000663	CcSEcCtD
Tiotropium—Oedema—Ramipril—type 2 diabetes mellitus	0.000163	0.000657	CcSEcCtD
Tiotropium—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000163	0.000656	CcSEcCtD
Tiotropium—Constipation—Losartan—type 2 diabetes mellitus	0.000162	0.000656	CcSEcCtD
Tiotropium—Rash—Gliclazide—type 2 diabetes mellitus	0.000161	0.000651	CcSEcCtD
Tiotropium—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000161	0.00065	CcSEcCtD
Tiotropium—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00016	0.000647	CcSEcCtD
Tiotropium—Shock—Ramipril—type 2 diabetes mellitus	0.00016	0.000647	CcSEcCtD
Tiotropium—Headache—Gliclazide—type 2 diabetes mellitus	0.00016	0.000646	CcSEcCtD
Tiotropium—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00016	0.000645	CcSEcCtD
Tiotropium—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00016	0.000644	CcSEcCtD
Tiotropium—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000159	0.000642	CcSEcCtD
Tiotropium—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000158	0.000639	CcSEcCtD
Tiotropium—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000155	0.000627	CcSEcCtD
Tiotropium—Dizziness—Valsartan—type 2 diabetes mellitus	0.000155	0.000627	CcSEcCtD
Tiotropium—Dizziness—Orlistat—type 2 diabetes mellitus	0.000153	0.000619	CcSEcCtD
Tiotropium—Nausea—Gliclazide—type 2 diabetes mellitus	0.000152	0.000613	CcSEcCtD
Tiotropium—Pruritus—Metformin—type 2 diabetes mellitus	0.000151	0.000611	CcSEcCtD
Tiotropium—Urticaria—Losartan—type 2 diabetes mellitus	0.000151	0.000609	CcSEcCtD
Tiotropium—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00015	0.000606	CcSEcCtD
Tiotropium—Vomiting—Valsartan—type 2 diabetes mellitus	0.000149	0.000603	CcSEcCtD
Tiotropium—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000149	0.0006	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000148	0.000599	CcSEcCtD
Tiotropium—Rash—Valsartan—type 2 diabetes mellitus	0.000148	0.000598	CcSEcCtD
Tiotropium—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000148	0.000597	CcSEcCtD
Tiotropium—Vomiting—Orlistat—type 2 diabetes mellitus	0.000148	0.000596	CcSEcCtD
Tiotropium—Insomnia—Ramipril—type 2 diabetes mellitus	0.000147	0.000595	CcSEcCtD
Tiotropium—Headache—Valsartan—type 2 diabetes mellitus	0.000147	0.000594	CcSEcCtD
Tiotropium—Rash—Orlistat—type 2 diabetes mellitus	0.000146	0.000591	CcSEcCtD
Tiotropium—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000146	0.00059	CcSEcCtD
Tiotropium—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000146	0.00059	CcSEcCtD
Tiotropium—Headache—Orlistat—type 2 diabetes mellitus	0.000145	0.000587	CcSEcCtD
Tiotropium—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000143	0.000579	CcSEcCtD
Tiotropium—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000143	0.000576	CcSEcCtD
Tiotropium—Dizziness—Metformin—type 2 diabetes mellitus	0.000141	0.000571	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000141	0.000568	CcSEcCtD
Tiotropium—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00014	0.000565	CcSEcCtD
Tiotropium—Nausea—Valsartan—type 2 diabetes mellitus	0.00014	0.000563	CcSEcCtD
Tiotropium—Constipation—Ramipril—type 2 diabetes mellitus	0.000139	0.000562	CcSEcCtD
Tiotropium—Nausea—Orlistat—type 2 diabetes mellitus	0.000138	0.000556	CcSEcCtD
Tiotropium—Vomiting—Metformin—type 2 diabetes mellitus	0.000136	0.000549	CcSEcCtD
Tiotropium—Rash—Metformin—type 2 diabetes mellitus	0.000135	0.000544	CcSEcCtD
Tiotropium—Dermatitis—Metformin—type 2 diabetes mellitus	0.000135	0.000544	CcSEcCtD
Tiotropium—Pruritus—Losartan—type 2 diabetes mellitus	0.000134	0.000542	CcSEcCtD
Tiotropium—Headache—Metformin—type 2 diabetes mellitus	0.000134	0.000541	CcSEcCtD
Tiotropium—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000133	0.000539	CcSEcCtD
Tiotropium—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000133	0.000538	CcSEcCtD
Tiotropium—Urticaria—Ramipril—type 2 diabetes mellitus	0.000129	0.000522	CcSEcCtD
Tiotropium—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000129	0.00052	CcSEcCtD
Tiotropium—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000128	0.000518	CcSEcCtD
Tiotropium—Rash—Irbesartan—type 2 diabetes mellitus	0.000127	0.000514	CcSEcCtD
Tiotropium—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000127	0.000513	CcSEcCtD
Tiotropium—Nausea—Metformin—type 2 diabetes mellitus	0.000127	0.000513	CcSEcCtD
Tiotropium—Headache—Irbesartan—type 2 diabetes mellitus	0.000126	0.00051	CcSEcCtD
Tiotropium—Dizziness—Losartan—type 2 diabetes mellitus	0.000126	0.000507	CcSEcCtD
Tiotropium—Vomiting—Losartan—type 2 diabetes mellitus	0.000121	0.000487	CcSEcCtD
Tiotropium—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00012	0.000484	CcSEcCtD
Tiotropium—Nausea—Irbesartan—type 2 diabetes mellitus	0.00012	0.000484	CcSEcCtD
Tiotropium—Rash—Losartan—type 2 diabetes mellitus	0.00012	0.000483	CcSEcCtD
Tiotropium—Dermatitis—Losartan—type 2 diabetes mellitus	0.00012	0.000483	CcSEcCtD
Tiotropium—Headache—Losartan—type 2 diabetes mellitus	0.000119	0.00048	CcSEcCtD
Tiotropium—Pruritus—Ramipril—type 2 diabetes mellitus	0.000115	0.000465	CcSEcCtD
Tiotropium—Nausea—Losartan—type 2 diabetes mellitus	0.000113	0.000455	CcSEcCtD
Tiotropium—Dizziness—Ramipril—type 2 diabetes mellitus	0.000108	0.000435	CcSEcCtD
Tiotropium—Vomiting—Ramipril—type 2 diabetes mellitus	0.000104	0.000418	CcSEcCtD
Tiotropium—Rash—Ramipril—type 2 diabetes mellitus	0.000103	0.000415	CcSEcCtD
Tiotropium—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000103	0.000414	CcSEcCtD
Tiotropium—Headache—Ramipril—type 2 diabetes mellitus	0.000102	0.000412	CcSEcCtD
Tiotropium—Nausea—Ramipril—type 2 diabetes mellitus	9.68e-05	0.00039	CcSEcCtD
Tiotropium—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.93e-06	9.78e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.92e-06	9.77e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.89e-06	9.74e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.87e-06	9.73e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	9.87e-06	9.72e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.84e-06	9.7e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	9.83e-06	9.69e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.83e-06	9.69e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.79e-06	9.65e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.77e-06	9.63e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.77e-06	9.63e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.76e-06	9.62e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.75e-06	9.6e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.74e-06	9.6e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	9.68e-06	9.54e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.65e-06	9.51e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	9.63e-06	9.49e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	9.63e-06	9.49e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	9.63e-06	9.49e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	9.63e-06	9.49e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	9.6e-06	9.46e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.59e-06	9.45e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.56e-06	9.42e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	9.5e-06	9.36e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.47e-06	9.34e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.46e-06	9.33e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	9.45e-06	9.32e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.44e-06	9.31e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	9.37e-06	9.24e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	9.37e-06	9.23e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.35e-06	9.22e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—INS—type 2 diabetes mellitus	9.35e-06	9.21e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	9.22e-06	9.08e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.2e-06	9.06e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	9.19e-06	9.06e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	9.19e-06	9.05e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	9.17e-06	9.03e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	9.16e-06	9.03e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.15e-06	9.02e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	9.08e-06	8.95e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	9.07e-06	8.94e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.04e-06	8.91e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.04e-06	8.9e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9e-06	8.87e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9e-06	8.87e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.97e-06	8.84e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.88e-06	8.75e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	8.84e-06	8.71e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	8.84e-06	8.71e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	8.84e-06	8.71e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	8.84e-06	8.71e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	8.81e-06	8.68e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	8.71e-06	8.58e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	8.71e-06	8.58e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.62e-06	8.5e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.6e-06	8.47e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.59e-06	8.46e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.51e-06	8.39e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	8.49e-06	8.37e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.47e-06	8.35e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.47e-06	8.35e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.44e-06	8.32e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.36e-06	8.24e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	8.35e-06	8.23e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	8.35e-06	8.23e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	8.28e-06	8.16e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	8.25e-06	8.13e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.2e-06	8.08e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.2e-06	8.08e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	8.17e-06	8.05e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	8e-06	7.88e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.89e-06	7.78e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	7.88e-06	7.76e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.87e-06	7.76e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.87e-06	7.75e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.86e-06	7.75e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.85e-06	7.73e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—INS—type 2 diabetes mellitus	7.85e-06	7.73e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	7.84e-06	7.72e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.79e-06	7.68e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.77e-06	7.66e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	7.76e-06	7.65e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.73e-06	7.62e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	7.72e-06	7.6e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.71e-06	7.6e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.71e-06	7.59e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.71e-06	7.59e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	7.68e-06	7.57e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	7.68e-06	7.57e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.63e-06	7.52e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.62e-06	7.51e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	7.61e-06	7.5e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	7.61e-06	7.5e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.59e-06	7.48e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.52e-06	7.41e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.35e-06	7.25e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.27e-06	7.16e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.24e-06	7.14e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.2e-06	7.1e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.2e-06	7.1e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	7.2e-06	7.09e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.2e-06	7.09e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	7.19e-06	7.09e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.17e-06	7.07e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	7.16e-06	7.06e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	7.07e-06	6.97e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.06e-06	6.96e-05	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.03e-06	6.92e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.02e-06	6.92e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.02e-06	6.92e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.02e-06	6.92e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	6.98e-06	6.87e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.96e-06	6.86e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.92e-06	6.81e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	6.88e-06	6.78e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	6.88e-06	6.78e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.87e-06	6.77e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	6.86e-06	6.76e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	6.85e-06	6.75e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.85e-06	6.75e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.79e-06	6.69e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.77e-06	6.67e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	6.68e-06	6.58e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	6.58e-06	6.49e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.58e-06	6.48e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	6.56e-06	6.47e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	6.55e-06	6.46e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.51e-06	6.41e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	6.5e-06	6.4e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.48e-06	6.38e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.46e-06	6.36e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	6.41e-06	6.32e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.39e-06	6.3e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	6.39e-06	6.3e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.38e-06	6.29e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.37e-06	6.27e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.36e-06	6.27e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.35e-06	6.25e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.34e-06	6.25e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.34e-06	6.24e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.32e-06	6.22e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.3e-06	6.2e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.3e-06	6.2e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.3e-06	6.2e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	6.29e-06	6.2e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.29e-06	6.19e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.28e-06	6.19e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.25e-06	6.16e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	6.23e-06	6.14e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.18e-06	6.09e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	6.15e-06	6.06e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.13e-06	6.04e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	6.06e-06	5.98e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.05e-06	5.96e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.03e-06	5.94e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.99e-06	5.91e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.97e-06	5.88e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.91e-06	5.82e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.9e-06	5.81e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	5.79e-06	5.7e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.77e-06	5.69e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.77e-06	5.69e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.76e-06	5.67e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.75e-06	5.67e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.75e-06	5.67e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.7e-06	5.62e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.7e-06	5.62e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.69e-06	5.61e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.69e-06	5.61e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	5.61e-06	5.52e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	5.51e-06	5.43e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	5.49e-06	5.41e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.46e-06	5.38e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.46e-06	5.38e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.43e-06	5.35e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	5.43e-06	5.35e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.42e-06	5.34e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.42e-06	5.34e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.36e-06	5.29e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.32e-06	5.24e-05	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.95e-06	4.87e-05	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.93e-06	4.86e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.9e-06	4.83e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.89e-06	4.81e-05	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.88e-06	4.81e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.87e-06	4.8e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.85e-06	4.78e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.84e-06	4.77e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.81e-06	4.74e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.78e-06	4.71e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.71e-06	4.64e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.71e-06	4.64e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.69e-06	4.62e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.68e-06	4.62e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.63e-06	4.56e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.62e-06	4.55e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.62e-06	4.55e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.58e-06	4.52e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.57e-06	4.51e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.57e-06	4.5e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.52e-06	4.46e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.49e-06	4.43e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.49e-06	4.42e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.48e-06	4.41e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.43e-06	4.37e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.36e-06	4.3e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	4.3e-06	4.24e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.28e-06	4.22e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.27e-06	4.21e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.26e-06	4.19e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.21e-06	4.15e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.19e-06	4.13e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.18e-06	4.12e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.16e-06	4.1e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.15e-06	4.09e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.11e-06	4.05e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.11e-06	4.05e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.11e-06	4.05e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	4.09e-06	4.03e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.07e-06	4.01e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.02e-06	3.96e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.86e-06	3.8e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.82e-06	3.76e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.8e-06	3.75e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.78e-06	3.73e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.77e-06	3.71e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.77e-06	3.71e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.76e-06	3.71e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.74e-06	3.69e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.73e-06	3.68e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.69e-06	3.64e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.66e-06	3.61e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.6e-06	3.55e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.59e-06	3.54e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.55e-06	3.5e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	3.16e-06	3.12e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.13e-06	3.08e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.07e-06	3.02e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.88e-06	2.83e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.87e-06	2.83e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.84e-06	2.8e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.81e-06	2.77e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.69e-06	2.65e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.69e-06	2.65e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.65e-06	2.61e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.65e-06	2.61e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.62e-06	2.58e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.46e-06	2.42e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.89e-06	1.86e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	1.22e-05	CbGpPWpGaD
